CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapy

Glioblastoma is the most common and aggressive type of brain tumor with high recurrence and fatality rates. Although various therapeutic strategies have been explored, there is currently no effective treatment for glioblastoma. Recently, the number of immunotherapeutic strategies has been tested for...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cancer Immunol Immunother
Huvudupphovsmän: Hara, Ayaka, Koyama-Nasu, Ryo, Takami, Mariko, Toyoda, Takahide, Aoki, Takahiro, Ihara, Fumie, Kobayashi, Masayoshi, Hirono, Seiichiro, Matsutani, Tomoo, Nakayama, Toshinori, Iwadate, Yasuo, Motohashi, Shinichiro
Materialtyp: Artigo
Språk:Inglês
Publicerad: Springer Berlin Heidelberg 2020
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8053161/
https://ncbi.nlm.nih.gov/pubmed/33128583
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-020-02742-1
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk